They have discovered how the anti-tumor activity of immune
cells can be restored
The Leuven-based VIB researchers have revealed a mechanism
that explains why the anti-tumor activity of specific immune cells called
macrophages is suppressed during tumor growth. They have also demonstrated that
blocking the protein Nrp1 can restore this anti-tumor immune response. This is
a first. Nrp1 may provide an important hub for the development of new therapies
against cancer.